Zdrowie i gospodarka · 01/03/2010
FDA Releases Draft Guidance for Non-Inferiority Clinical Trials
The Food and Drug Administration (FDA) has made available a draft guidance document outlining the agency's interpretation of non-inferiority clinical trials, which are used to demonstrate the effectiveness of new drugs or biologics.
Source: Federal Register — Health and Human ServicesOpen original release →